Meeting of Council for International Organisations of Medical Sciences (CIOMS), Geneva, Switzerland, 5-6 November 1997: Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): Cardiovascular system disorders
(18)
Aellig, W
a
Bankowski, Z
a
Bruppacher, R
a
Crusius, I
a
Fenichel, R
a
Gallagher, J
a
Idanpaan Heikkila, J E
a
Kappenberger, L
a
Kremer, G
a
Kreutz, G
a
Mann, R D
a
Nordet, P
a
Pfeiffer, M
a
Prichard, B N C
a
Strebel, L
a
Ten Ham, M
a
Trubestein, G
a
Venulet, J
a
|
-
2
-
-
0025075173
-
Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: Report of an International Consensus Meeting
-
Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an International Consensus Meeting. International Journal of Clinical Pharmacology, Therapy and Toxicology (1990); 28(8): 317-322.
-
(1990)
International Journal of Clinical Pharmacology, Therapy and Toxicology
, vol.28
, Issue.8
, pp. 317-322
-
-
-
3
-
-
0025963481
-
Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia
-
Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia. International Journal of Clinical Pharmacology, Therapy and Toxicology 1991; 29(2): 75-81.
-
(1991)
International Journal of Clinical Pharmacology, Therapy and Toxicology
, vol.29
, Issue.2
, pp. 75-81
-
-
-
4
-
-
85025270206
-
Basic requirements for the use of terms for reporting adverse drug reactions. Anaphylactic shock, arrhythmia, cardiac failure, hypertension, thrombosis and embolism
-
Basic requirements for the use of terms for reporting adverse drug reactions. Anaphylactic shock, arrhythmia, cardiac failure, hypertension, thrombosis and embolism. Pharmacoepidemiology and Drug Safety 1992; 1: 39-45.
-
(1992)
Pharmacoepidemiology and Drug Safety
, vol.1
, pp. 39-45
-
-
-
5
-
-
85025275650
-
Basic requirements for the use of terms for reporting adverse drug reactions (II). Colitis, gastrointestinal haemorrhage, hepatocellular damage, peptic ulcer, pancreatitis
-
Basic requirements for the use of terms for reporting adverse drug reactions (II). Colitis, gastrointestinal haemorrhage, hepatocellular damage, peptic ulcer, pancreatitis. Pharmacoepidemiology and Drug Safety 1992; 1: 133-137.
-
(1992)
Pharmacoepidemiology and Drug Safety
, vol.1
, pp. 133-137
-
-
-
6
-
-
85025300635
-
Basic requirements for the use of terms for reporting adverse drug reactions (III). Aplastic anaemia, bone marrow depression, coagulation disorders, agranulocytosis, thrombophlebitis
-
Basic requirements for the use of terms for reporting adverse drug reactions (III). Aplastic anaemia, bone marrow depression, coagulation disorders, agranulocytosis, thrombophlebitis. Pharmacoepidemiology and Drug Safety 1992; 1: 191-196.
-
(1992)
Pharmacoepidemiology and Drug Safety
, vol.1
, pp. 191-196
-
-
-
7
-
-
85025286376
-
Basic requirements for the use of terms for reporting adverse drug reactions (IV). Diskinesia, depression, myopathy, neuropathy, paralysis, convulsions
-
Basic requirements for the use of terms for reporting adverse drug reactions (IV). Diskinesia, depression, myopathy, neuropathy, paralysis, convulsions. Pharmacoepidemiology and Drug Safety 1993; 2: 149-153.
-
(1993)
Pharmacoepidemiology and Drug Safety
, vol.2
, pp. 149-153
-
-
-
8
-
-
85025260185
-
Basic requirements for the use of terms for reporting adverse drug reactions (V). Vision abnormal, keratitis, cataract, retinal disorder, acidosis
-
Basic requirements for the use of terms for reporting adverse drug reactions (V). Vision abnormal, keratitis, cataract, retinal disorder, acidosis. Pharmacoepidemiology and Drug Safety 1993; 2: 189-193.
-
(1993)
Pharmacoepidemiology and Drug Safety
, vol.2
, pp. 189-193
-
-
-
9
-
-
0344966111
-
Definition of adverse drug reactions and minimum requirements for their use: Cardiovascular disease terms
-
Definition of adverse drug reactions and minimum requirements for their use: cardiovascular disease terms. Pharmacoepidemiology and Drug Safety 1993: 2: 591-602.
-
(1993)
Pharmacoepidemiology and Drug Safety
, vol.2
, pp. 591-602
-
-
-
10
-
-
0031001444
-
Harmonizing the use of adverse-drug-reaction terms. Definitions of terms and minimum requirements for their use: Respiratory disorders and skin disorders
-
Harmonizing the use of adverse-drug-reaction terms. Definitions of terms and minimum requirements for their use: respiratory disorders and skin disorders. Pharmacoepidemiology and Drug Safety 1997; 6: 115-127.
-
(1997)
Pharmacoepidemiology and Drug Safety
, vol.6
, pp. 115-127
-
-
-
11
-
-
12644280836
-
Basic requirements for the use of terms for reporting adverse drug reactions (VIII): Renal and urinary system disorders
-
Basic requirements for the use of terms for reporting adverse drug reactions (VIII): Renal and urinary system disorders. Pharmacoepidemiology and Drug Safety 1997; 6: 203-211.
-
(1997)
Pharmacoepidemiology and Drug Safety
, vol.6
, pp. 203-211
-
-
-
12
-
-
13144254241
-
Basic requirements for the use of terms for reporting adverse drug reactions (IX). Nervous system and psychiatric disorders
-
Basic requirements for the use of terms for reporting adverse drug reactions (IX). Nervous system and psychiatric disorders. Pharmacoepidemiology and Drug Safety 1998; 7: 39-49.
-
(1998)
Pharmacoepidemiology and Drug Safety
, vol.7
, pp. 39-49
-
-
-
13
-
-
13144295162
-
Basic requirements for the use of terms for reporting adverse drug reactions (X). Gastrointestinal system disorders
-
in press
-
Basic requirements for the use of terms for reporting adverse drug reactions (X). Gastrointestinal system disorders. Pharmacoepidemiology and Drug Safety (in press).
-
Pharmacoepidemiology and Drug Safety
-
-
|